Fermenta Biotech Ltd

Fermenta Biotech Ltd

Fermenta Biotech Ltd has announced an investor meeting on October 15, 2026, in Dahej, Gujarat, to discuss press releases and investor presentations available on the company's website and stock exchanges.

Fermenta Biotech Ltd

Fermenta Biotech Ltd has announced an investor meeting on October 14, 2026, where the company officials will interact with individual investors. The meeting will be held physically in Mumbai. The company has made available relevant press releases and investor presentations on its website and stock exchange websites, and no unpublished price-sensitive information will be discussed during the interaction.

Fermenta Biotech Ltd

Fermenta Biotech Ltd has provided a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities for the quarter ended September 30, 2026.

Fermenta Biotech Ltd

Fermenta Biotech Ltd has announced an investor meeting on October 07, 2026, in Mumbai, where company officials will discuss press releases and investor presentations available on the company's website and stock exchanges.

Fermenta Biotech Ltd

Fermenta Biotech Ltd's promoter, Preeti Thakkar, has sold 11,65,933.89 (3.96%) equity shares of the company in the open market on September 28, 2026.

Fermenta Biotech Ltd

Fermenta Biotech Ltd has announced an investor meeting to be held on October 5, 2026, in Mumbai. The meeting will be attended by the company's officials and will discuss the company's press releases and investor presentations available on its website and stock exchanges.

Fermenta Biotech Ltd

Fermenta Biotech Ltd has announced the closure of its trading window from October 1, 2026, until 48 hours after the announcement of unaudited financial results for the quarter and half year ending September 30, 2026. The company's directors, promoters, insiders, and designated persons, including auditors, are prohibited from trading or dealing in the company's equity shares during this period.

Fermenta Biotech Ltd

Fermenta Biotech Ltd has announced an investor meeting on September 29, 2026, in Mumbai, where company officials will discuss press releases and investor presentations available on the company's website and stock exchanges.

Fermenta Biotech Ltd

Fermenta Biotech Ltd has announced an investor meeting on September 24, 2026, in Mumbai, where company officials will discuss press releases and investor presentations available on the company's website and stock exchanges.

Fermenta Biotech Ltd

Fermenta Biotech Ltd has published a notice to equity shareholders regarding the transfer of shares to the Investor Education and Protection Fund (IEPF) due to non-payment of rent on locker facilities.

Fermenta Biotech Ltd

Fermenta Biotech Ltd has dispatched letters to shareholders regarding the transfer of unclaimed equity shares to the Investor Education and Protection Fund (IEPF) account due to non-encashment of dividend for seven consecutive years.

Fermenta Biotech Ltd

Fermenta Biotech Ltd has announced an investor meeting on September 3, 2026, in Mumbai, where company officials will discuss press releases and investor presentations available on the company's website and stock exchanges.

Fermenta Biotech Ltd

Fermenta Biotech Ltd has published a notice for a special window for transfer and dematerialization of physical securities in Business Standard and Sakal newspapers on August 26, 2026.

Fermenta Biotech Ltd

Fermenta Biotech Ltd has announced an investor meeting to be held on August 21, 2026, where the company officials will interact with investors. The meeting will be held in Mumbai and will discuss the company's press releases and investor presentations available on its website and stock exchange websites.

Fermenta Biotech Ltd

Fermenta Biotech Ltd has received a letter from CARE Ratings Ltd informing a revision in its credit rating. CARE's Rating Committee has upgraded the ratings for the company's long-term and short-term bank facilities.

Fermenta Biotech Ltd

Fermenta Biotech Ltd has published its unaudited financial results for the quarter ended June 30, 2026, in newspapers as per Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Fermenta Biotech Ltd

Fermenta Biotech Ltd held its 74th Annual General Meeting on August 11, 2026, through Video Conferencing/Other Audio Visual Means. The meeting commenced at 3:00 p.m. (IST) and concluded at 5:12 p.m. (IST). The results of remote e-voting (including ballot forms) and electronic voting on all the resolutions set out in the notice of the 74th Annual General Meeting were declared. All resolutions were duly approved by the members with requisite majority.

Fermenta Biotech Ltd

Fermenta Biotech Ltd has announced the voting results of its 74th Annual General Meeting, where all resolutions were passed with the requisite majority. The company has declared a dividend of Rs. 3.75 per equity share and appointed a new director in place of Ms. Rajeshwari Datla. The resolutions related to the appointment and continuation of Ms. Datla as a Non-Executive Director were also approved.

Fermenta Biotech Ltd

Fermenta Biotech Ltd's 74th Annual General Meeting (AGM) has approved the appointment of Ms. Rajeshwari Datla as a Non-Executive Director, payment of a 75% dividend of Rs. 3.75 per equity share, and commission to Non-Executive Directors. The meeting also approved material related party transactions with Fermenta USA LLC, a step-down subsidiary.

Fermenta Biotech Ltd

Fermenta Biotech Ltd has announced its 74th Annual General Meeting presentation, highlighting its operating momentum, renewed strategic conviction, and capital commitment. The company has achieved a record topline of ₹548 crore, up 14% from ₹481 crore in FY25, and has granted a patent for its plant-source Vitamin D3 process. It has also secured EDQM CEP for D3 100 SD and approved ₹110 crore of new Dahej capacity.